PA8786701A1 - Comp. farmaceutica en la forma de polvos encapsulados q' comprende orlistat, proc. de prep. de la comp. y su uso para el ....... - Google Patents
Comp. farmaceutica en la forma de polvos encapsulados q' comprende orlistat, proc. de prep. de la comp. y su uso para el .......Info
- Publication number
- PA8786701A1 PA8786701A1 PA20088786701A PA8786701A PA8786701A1 PA 8786701 A1 PA8786701 A1 PA 8786701A1 PA 20088786701 A PA20088786701 A PA 20088786701A PA 8786701 A PA8786701 A PA 8786701A PA 8786701 A1 PA8786701 A1 PA 8786701A1
- Authority
- PA
- Panama
- Prior art keywords
- comp
- orlistat
- mix
- glidant
- agent
- Prior art date
Links
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title abstract 3
- 229960001243 orlistat Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 2
- 239000012895 dilution Substances 0.000 abstract 2
- 239000000314 lubricant Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 229950004297 lauril Drugs 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940023144 sodium glycolate Drugs 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2007002287A CL53426B (enExample) | 2007-08-06 | 2007-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8786701A1 true PA8786701A1 (es) | 2009-04-23 |
Family
ID=51359501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20088786701A PA8786701A1 (es) | 2007-08-06 | 2008-07-01 | Comp. farmaceutica en la forma de polvos encapsulados q' comprende orlistat, proc. de prep. de la comp. y su uso para el ....... |
Country Status (7)
| Country | Link |
|---|---|
| CL (1) | CL53426B (enExample) |
| CR (1) | CR10132A (enExample) |
| DO (1) | DOP2008000021A (enExample) |
| MX (1) | MX2008010082A (enExample) |
| PA (1) | PA8786701A1 (enExample) |
| PE (1) | PE20091224A1 (enExample) |
| SV (1) | SV2009002991A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216542B1 (pl) * | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
-
2007
- 2007-08-06 CL CL2007002287A patent/CL53426B/es active
- 2007-10-25 PE PE2007001452A patent/PE20091224A1/es active IP Right Grant
-
2008
- 2008-04-10 DO DO2008000021A patent/DOP2008000021A/es unknown
- 2008-07-01 PA PA20088786701A patent/PA8786701A1/es unknown
- 2008-07-07 CR CR10132A patent/CR10132A/es not_active Application Discontinuation
- 2008-07-31 SV SV2008002991A patent/SV2009002991A/es unknown
- 2008-08-06 MX MX2008010082A patent/MX2008010082A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DOP2008000021A (es) | 2009-11-30 |
| CR10132A (es) | 2008-10-28 |
| CL2007002287A1 (enExample) | 2007-12-14 |
| MX2008010082A (es) | 2009-04-17 |
| PE20091224A1 (es) | 2009-08-26 |
| CL53426B (enExample) | 2016-11-28 |
| SV2009002991A (es) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| IS8669A (is) | Rasagilínlyfjablöndur sem einsleitni innihaldsefna hefur verið endurbætt í | |
| CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
| MY149869A (en) | Thiophene derivatives as s1p1/edg1 receptor agonists | |
| EA201001852A1 (ru) | Твердые фармацевтические составы, содержащие bibw 2992 | |
| BRPI0914902B8 (pt) | Composição farmacêutica para uso no tratamento de mal de parkinson | |
| TN2017000467A1 (en) | Amido-substituted cyclohexane derivatives | |
| CL2015001945A1 (es) | (divisional de la solicitud n° 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
| EA200700501A1 (ru) | Композиция (варианты) и способ для лечения гиперпролиферативных процессов, способ лечения рака (варианты) и способ получения твёрдой дисперсии вещества | |
| BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
| AR111570A1 (es) | Composición farmacéutica que comprende selexipag | |
| CO6761350A2 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis | |
| BR112013015786A2 (pt) | composição de agente de formação de imagem, método de formação de imagem de pelo menos uma parte de um indivíduo, e, método para preparar uma composição de polipeptídeo conjugado com quelante | |
| WO2009074950A3 (en) | Thiophene derivatives as agonists of s1p1/edg1 | |
| MY157661A (en) | Bendamustine pharmaceutical compositions | |
| AR041370A1 (es) | Formulaciones farmaceuticas solidas que comprenden telmisartano y su preparacion | |
| AR057099A1 (es) | Una forma cristalina, un proceso de preparacion y composicion farmaceutica | |
| WO2009120389A8 (en) | Oral and injectable formulations of tetracycline compounds | |
| TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
| WO2016184577A3 (en) | Dry powder composition comprising long-chain rna | |
| SA518400501B1 (ar) | مركبات [8- (فنيل سلفونيل)-3، 8-ديازا ثنائي سيكلو [3. 2. 1] أوكتـ-3-يل] ميثانون (1h-1، 2، 3-تريازول-4-يل) | |
| PE20120422A1 (es) | Formulaciones orales solidas de (r)-2-amino-7-[4-fluoro-2-(6-metoxi-piridin-2-il)-fenil]-4-metil-7,8-dihidro-6h-pirido-[4,3-d]-pirimidin-5-ona | |
| AR102779A1 (es) | Composición farmacéutica, su preparación y sus usos | |
| ES2922903T3 (es) | Composición farmacéutica que comprende sales de lenvatinib | |
| CR20190298A (es) | Amidas aromáticas de ácido carboxílico |